Evidence map›Paper›PMID 33320908›Full record

ArticlePloS one2020

Scanning single-molecule counting system for Eprobe with highly simple and effective approach.

Takeshi Hanami, Tetsuya Tanabe, Takuya Hanashi, Mitsushiro Yamaguchi, Hidetaka Nakata, Yasumasa Mitani, Yasumasa Kimura, Takahiro Soma, Kengo Usui, Michiko Isobe and 4 more

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Takeshi HanamiGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.ORCID 0000-0003-1868-1409
Tetsuya TanabeGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.
Takuya HanashiGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.
Mitsushiro YamaguchiGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.
Hidetaka NakataRIKEN Innovation Center, Wako, Saitama, Japan.
Yasumasa MitaniK.K. DNAFORM, Yokohama, Kanagawa, Japan.
Yasumasa KimuraK.K. DNAFORM, Yokohama, Kanagawa, Japan.
Takahiro SomaGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.
Kengo UsuiGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.
Michiko IsobeRIKEN Innovation Center, Wako, Saitama, Japan.
Takashi OgawaRIKEN Innovation Center, Wako, Saitama, Japan.
Masayoshi ItohGenetic Diagnosis Technology Unit, RIKEN Center for Integrative Medical Science, Yokohama, Kanagawa, Japan.ORCID 0000-0002-1772-318X
Yoshihide HayashizakiRIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Saitama, Japan.
Seiji KondoRIKEN Innovation Center, Wako, Saitama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we report a rapid and ultra-sensitive detection technique for fluorescent molecules called scanning single molecular counting (SSMC). The method uses a fluorescence-based digital measurement system to count single molecules in a solution. In this technique, noise is reduced by conforming the signal shape to the intensity distribution of the excitation light via a circular scan of the confocal region. This simple technique allows the fluorescent molecules to freely diffuse into the solution through the confocal region and be counted one by one and does not require statistical analysis. Using this technique, 28 to 62 aM fluorescent dye was detected through measurement for 600 s. Furthermore, we achieved a good signal-to-noise ratio (S/N = 2326) under the condition of 100 pM target nucleic acid by only mixing a hybridization-sensitive fluorescent probe, called Eprobe, into the target oligonucleotide solution. Combination of SSMC and Eprobe provides a simple, rapid, amplification-free, and high-sensitive target nucleic acid detection system. This method is promising for future applications to detect particularly difficult to design primers for amplification as miRNAs and other short oligo nucleotide biomarkers by only hybridization with high sensitivity.

Indexed as

FluorescenceFluorescent DyesMicroRNAsNucleic Acid HybridizationOligonucleotidesFluorescent DyesMicroRNAsOligonucleotides

Identifiers

PMID33320908
PMCPMC7737986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.